Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics

ER Siuda, R Carr III, DH Rominger, JD Violin - Current opinion in …, 2017 - Elsevier
Highlights • Biased MOR ligands discovered using empirical, rational and natural product
approaches. • Biased MOR ligands produce analgesia with fewer side effects in mice and …

AG protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine

SM DeWire, DS Yamashita, DH Rominger, G Liu… - … of Pharmacology and …, 2013 - ASPET
The concept of ligand bias at G protein-coupled receptors broadens the possibilities for
agonist activities and provides the opportunity to develop safer, more selective therapeutics. …

Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance

…, SM DeWire, D Yamashita, DH Rominger… - … of Pharmacology and …, 2010 - ASPET
Biased G protein-coupled receptor ligands engage subsets of the receptor signals normally
stimulated by unbiased agonists. However, it is unclear whether ligand bias can elicit …

Quantifying ligand bias at seven-transmembrane receptors

S Rajagopal, S Ahn, DH Rominger… - Molecular …, 2011 - ASPET
Seven transmembrane receptors (7TMRs), commonly referred to as G protein-coupled
receptors, form a large part of the “druggable” genome. 7TMRs can signal through parallel …

[HTML][HTML] Presenilin-1 and-2 are molecular targets for γ-secretase inhibitors

…, JD Bradley, CM Rominger, DH Rominger… - Journal of Biological …, 2000 - ASBMB
Presenilins are integral membrane protein involved in the production of amyloid β-protein.
Mutations of the presenilin-1 and -2 gene are associated with familial Alzheimer's disease …

[HTML][HTML] Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

R Kumar, MC Crouthamel, DH Rominger… - British journal of …, 2009 - nature.com
Background: Myelosuppression has been observed with several multikinase angiogenesis
inhibitors in clinical studies, although the frequency and severity varies among the different …

Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro …

…, D Gotchev, CL Cowan, DH Rominger… - Journal of medicinal …, 2013 - ACS Publications
The concept of “ligand bias” at G protein coupled receptors has been introduced to describe
ligands which preferentially stimulate one intracellular signaling pathway over another. …

Two new potent neurotransmitter release enhancers, 10, 10-bis (4-pyridinylmethyl)-9 (10H)-anthracenone and 10, 10-bis (2-fluoro-4-pyridinylmethyl)-9 (10H) …

…, AR Logue, BN Fisher, DH Rominger… - … of Pharmacology and …, 1998 - ASPET
Linopirdine (3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-one, DUP996) is an extensively
studied representative of a class of cognition enhancing compounds that increase the evoked …

[HTML][HTML] Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR)

RT Strachan, J Sun, DH Rominger, JD Violin… - Journal of Biological …, 2014 - ASBMB
The concept of "biased agonism" arises from the recognition that the ability of an agonist to
induce a receptor-mediated response (ie "efficacy") can differ across the multiple signal …

Evidence for allosteric interactions of antagonist binding to the smoothened receptor

…, B Turunen, M Will, WJ Zuercher, DH Rominger - … of Pharmacology and …, 2009 - ASPET
The Smoothened receptor (Smo) mediates hedgehog (Hh) signaling critical for development,
cell growth, and migration, as well as stem cell maintenance. Aberrant Hh signaling …